四川省长征药业股份有限公司
- Country
- Ownership
- -
- Established
- 1993-04-19
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
119
NMPA:119
Drug Approvals
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑啉钠
- Approval Number
- 国药准字H51020688
- Approval Date
- Jun 23, 2022
NMPA
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑啉钠
- Approval Number
- 国药准字H51020689
- Approval Date
- Jun 23, 2022
NMPA
Cefoperazone Sodium for Injection
- Product Name
- 注射用头孢哌酮钠
- Approval Number
- 国药准字H20043286
- Approval Date
- Jun 23, 2021
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H51020690
- Approval Date
- Jun 23, 2021
NMPA
Ceftriaxone Sodium for Injection
- Product Name
- 注射用头孢曲松钠
- Approval Number
- 国药准字H20034089
- Approval Date
- Jun 23, 2021
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20043465
- Approval Date
- Jun 23, 2021
NMPA
Cefoperazone Sodium for Injection
- Product Name
- 注射用头孢哌酮钠
- Approval Number
- 国药准字H20043287
- Approval Date
- Jun 23, 2021
NMPA
Cefuroxime Sodium for Injection
- Product Name
- 注射用头孢呋辛钠
- Approval Number
- 国药准字H20065526
- Approval Date
- Jun 23, 2021
NMPA
Lincomycin Hydrochloride Injection
- Product Name
- 盐酸林可霉素注射液
- Approval Number
- 国药准字H51022553
- Approval Date
- Jun 23, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
No trials found
News
No news found